Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novan Inc (NQ: NOVN )

1.350 +0.150 (+12.50%)
Streaming Delayed Price Updated: 3:28 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 691,162
Open 1.250
Bid (Size) 1.340 (10)
Ask (Size) 1.360 (1)
Prev. Close 1.200
Today's Range 1.250 - 1.540
52wk Range 0.7900 - 4.090
Shares Outstanding 18,813,192
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novan's Return On Capital Employed Overview
 
Via Benzinga
Earnings Scheduled For March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
Via Benzinga

Performance

YTD
-18.67%
-18.67%
1 Month
-4.93%
-4.93%
3 Month
+3.85%
+3.85%
6 Month
-27.42%
-27.42%
1 Year
-63.01%
-63.01%

More News

Read More
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
From Novan, Inc.
Via Globe NewsWire
Earnings Outlook For Novan
Via Benzinga
Looking Into Novan's Return On Capital Employed
Via Benzinga
Novan to Report Full Year 2022 Financial Results on March 30, 2023
From Novan, Inc.
Via Globe NewsWire
Novan Announces Closing of $6.0 Million Registered Direct Offering
From Novan, Inc.
Via Globe NewsWire
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Novan, Inc.
Via Globe NewsWire
Novan Announces $6.0 Million Registered Direct Offering
From Novan, Inc.
Via Globe NewsWire
Novan Moves Forward with Unified Corporate Branding
From Novan, Inc.
Via Globe NewsWire
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
From Novan, Inc.
Via Globe NewsWire
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
From Novan, Inc.
Via Globe NewsWire
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
Via ACCESSWIRE
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
From Novan, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
From Novan, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
From Novan, Inc.
Via Globe NewsWire
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
From Novan, Inc.
Via Globe NewsWire
Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Novan, Inc.
Via Globe NewsWire
Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
From Novan, Inc.
Via Globe NewsWire
EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference®
From Novan, Inc.
Via Globe NewsWire
Earnings Scheduled For November 14, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.